Your fact-checks will appear here
Pharmaceutical company
Available reporting in the search results treats “Neurocept” as a brain-health supplement newly marketed in 2025 and compares it broadly to other cognitive-support products . The dataset does not pres...
Pharmaceutical companies have sharply increased investment in oncology across R&D, licensing deals, M&A and manufacturing capacity, driven by a deep clinical pipeline, rising patient prevalence and th...
Federal disclosure and reporting show Jasmine Crockett accepted PAC money from a broad swath of corporate and trade PACs — telecom, pharmaceuticals, finance, defense contractors and major consumer bra...
OpenSecrets reports Pharmaceuticals/Health Products PACs gave $16,054,355 to federal candidates in 2024 (total from the industry PAC category) and abundance-of-detail databases and news coverage singl...
Dr. Mehmet Oz has disclosed advisory and investment ties to supplement seller iHerb and said he will divest or resign from certain roles if confirmed as CMS administrator; his ethics filing and subseq...
A targeted review of credible news coverage from 2023 through 2025 finds Major outlets that examined Oz’s investments and potential conflicts of interest catalogued holdings in health insurers, pharma...
Dr. Mehmet Oz’s public financial disclosures and reporting show he and his wife have owned stock in pharmaceutical companies, including Johnson & Johnson and others, but the records cited do not docum...